Hope For New Parkinson's Disease Treatment Through RXR Activation
 

Hope For New Parkinson's Disease Treatment Through RXR Activation

Medical News Today, 12 Dec 2009
Entire item at: http://www.medicalnewstoday.com/articles/173752.php

Following up on their previous work showing the rescue of dopamine neurons by chemicals that interact with the retinoid X receptor (RXR), researchers have now investigated the potential of these chemicals, known as RXR ligands, for the treatment of Parkinson's disease. Writing in the open access journal BMC Neuroscience the scientists describe the use of two cellular models of Parkinsonian damage to explore the neuroprotective function of the two RXR ligands LG268 and XCT.